Articles in Point of View

Digital Health Funding in 2025: From Hype to Hard Results

In 2025, digital health funding reset around discipline, outcomes, and real-world impact—creating a stronger foundation for sustainable growth.

January 6, 2026 by Galen Growth Read article

In Uncertain Times, Innovation Lights the Way: Year-End Reflections

A year-end reflection on how healthcare innovation, AI, and digital health matured in 2025 despite geopolitical and economic uncertainty.

December 30, 2025 by Galen Growth Read article

The Twelve Days of Digital Health (2025 Edition)

This article provides a structured, evidence-led overview of digital health trends in 2025, covering pharma, payers, providers, regulators, and health technology vendors…

December 23, 2025 by Galen Growth Read article

Who has the Golden Checkbook: Inside the 50 Core Investors Re-Wiring Global Digital Health (2025)

The HT50 Core Investors 2025 report reveals the 50 investors shaping global digital health—across stages, regions and themes. Drawing on HealthTech Alpha…

December 16, 2025 by Galen Growth Read article

From Vision to Global Impact: Galen Growth Turns 10

In November 2015, five founders — Julien de Salaberry, Nawal Roy, Snehal Patel, Ronald Ling and Jeremy Sun — came together in…

December 9, 2025 by Galen Growth Read article

Who is really winning pharma’s digital health innovation race in 2025?

Galen Growth’s 2025 Pharmaceutical Digital Health Innovation Index ranks the 25 most active global pharma companies on how effectively they embed digital…

December 2, 2025 by Galen Growth Read article

The Great Remote Patient Monitoring Reckoning: Why UnitedHealthcare’s Policy Change Demands a Systemic Digital Health Reset

UnitedHealthcare’s rollback of remote patient monitoring coverage is a pivotal market signal exposing the unsustainable economics of CPT-dependent RPM companies. Beyond the…

November 25, 2025 by Galen Growth Read article

TrumpRx Drug Price Mandate Disrupts Pharma’s Direct-to-Patient (DTP) Evolution: 3 Key Hypotheses

TrumpRx Drug Price Mandate Disrupts Pharma’s Direct-to-Patient (DTP) Evolution: 3 Key Hypotheses

November 18, 2025 by Galen Growth Read article

Smart Trials, Swift Cures: How Regulators are Contributing to the Digital Transformation of Clinical Trials

Regulators are accelerating the digital transformation of clinical trials. The UK’s AI-driven approval reforms and the FDA’s digital health guidance signal a…

November 11, 2025 by Galen Growth Read article

Clearing the Bottleneck: How Digital Innovation Is Re-Engineering Clinical Trials

TL;DR — Why This Matters Clinical trials have become the biggest bottleneck in global drug development, consuming over half of all R&D…

November 4, 2025 by Galen Growth Read article

Beyond Funding: Evidence and Partnerships Give DiMe Seal Ventures the Edge

In the fast-paced world of digital health, credibility, validation, and trust are the key differentiators between ventures that thrive and those that…

October 21, 2025 by Galen Growth Read article

HealthTech 250 Thriving Amid Adversity – Mid-2025 Trends & Outlook

Galen Growth’s Unmatched Intelligence Identifies Digital Health’s Future Leaders This is Part 2 of our two-part series on the HealthTech 250 —…

September 2, 2025 by Galen Growth Read article